Login
$CURX
$4.95 +$0.19 (3.88%) Close

Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
ASSETS
Current assets
Cash
Prepaid Expenses
Other Current Assets
Total current assets
Right-of-Use Asset
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accrued expenses
Accounts payable
Interest payable
Lease Liability, current
Total current liabilities
Lease Liability, noncurrent
Loan from Shareholders
TOTAL LIABILITIES
Shareholders’ equity
Common stock, 475,000,000 shares authorized; $0.0001 par value; 28,364,812 and 28,340,812 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Preferred stock, 25,000,000 shares authorized; $0.0001 par value; 1,000,000 shares issued and outstanding as of June 30, 2026 and December 31, 2025
Common Stock to be Issued
Additional paid-in capital
Accumulated deficit
TOTAL SHAREHOLDERS’ EQUITY
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support